Real World Study of Classic Infectious Disease

Recruiting now

Conditions studied: Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar

In brief

This study aimed to collect and analyze clinical specimens of patients with classic infectious diseases in the real world. To investigate the epidemiological distribution of classic infectious diseases (brucellosis, epidemic hemorrhagic fever, kala-azar) and treatment options suitable for China.

Key facts

Study ID

NCT04020536

Run by

Huashan Hospital

People needed

10000

Starts

2020-05-13

Expected to finish

2029-06-01

Last updated by the study team

2020-05-14

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Brucellosis： Patients with any of the following confirmed the evidence.
• sample culture: Brucella;
• Specific antigen or antibody (IgG or IgM) positive. epidemic hemorrhagic fever：
• 1 specific antibody positive 2 Hantavirus RNA positive kala-azar：
• latent infection: rK39 antibody positive
• patients with the following evidence of kala-azar diagnosis: 1) bone marrow, spleen puncture sample culture: Leishmania; 2) bone marrow, spleen puncture sample smear: Leishmania; 3) clinical symptoms, history of exposure or epidemiology, and positive screening test (rK39 positive)

You may not qualify if…

• Patient history data is incomplete
• HIV antibody positive and AIDS patients
• Patients who participated in other clinical trials during the same period.
• Pregnant, lactating women or women of childbearing age who are ready to conceive.

Where it is running

• Huashan Hospital of Fudan University — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.